Cargando…
In Vitro Activity of the Sudapyridine (WX-081) against Non-Tuberculous Mycobacteria Isolated in Beijing, China
Sudapyridine (WX-081) is a structural analog of bedaquiline (BDQ), which shows an anti-tuberculosis activity but, unlike BDQ, did not prolong QT interval (QT) in animal model studies. This study evaluated the antimicrobial activity of this novel drug against non-tuberculous mycobacteria (NTM). Fifty...
Autores principales: | Zhu, Rui, Shang, Yuanyuan, Chen, Suting, Xiao, Hua, Ren, Ruyan, Wang, Fen, Xue, Yi, Li, Lei, Li, Yongguo, Chu, Naihui, Huang, Hairong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769519/ https://www.ncbi.nlm.nih.gov/pubmed/36250885 http://dx.doi.org/10.1128/spectrum.01372-22 |
Ejemplares similares
-
In vitro and Intracellular Antibacterial Activity of Sudapyridine (WX-081) Against Tuberculosis
por: Xiao, Hua, et al.
Publicado: (2023) -
Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus
por: Nie, Wenjuan, et al.
Publicado: (2023) -
Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
por: Yao, Rong, et al.
Publicado: (2022) -
Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates
por: Nie, Wenjuan, et al.
Publicado: (2015) -
Doubled Nontuberculous Mycobacteria Isolation as a Consequence of Changes in the Diagnosis Algorithm
por: Chen, Suting, et al.
Publicado: (2022)